{"@context":{"@vocab":"https://schema.org/","mk":"https://www.marlowekeynesinvest.com/vocab#"},"@type":"Organization","@id":"https://www.marlowekeynesinvest.com/#organization","name":"Marlowe Keynes Research","legalName":"Marlowe Keynes LLC","alternateName":["MK Research","Marlowe Keynes","Marlowe Research","MKR"],"description":"Independent institutional investment research firm providing conflict-free equity and macro analysis exclusively to hedge funds and major asset allocators.","url":"https://www.marlowekeynesinvest.com","foundingDate":"2024","address":{"@type":"PostalAddress","streetAddress":"915 Broadway, Suite 1802","addressLocality":"New York City","addressRegion":"NY","postalCode":"10010","addressCountry":"US"},"contactPoint":{"@type":"ContactPoint","email":"dsteinberg@marlowekeynes.com","contactType":"institutional enquiries","areaServed":"Global","availableLanguage":"English"},"industry":"Investment Research","naicsCode":"523999","numberOfEmployees":{"@type":"QuantitativeValue","value":12,"unitText":"senior analysts"},"serviceArea":{"@type":"Place","name":"Global"},"knowsAbout":["Institutional Investment Research","Equity Research","Macro Economics","Hedge Fund Analysis","Asset Allocation","Financial Analysis","Portfolio Management","Fundamental Analysis","Quantitative Finance"],"mk:clientEligibility":{"hedgeFunds":"$500M+ AUM","assetManagers":"$1B+ AUM","maxPartnerships":50},"mk:trackRecord":{"outperformanceRate":"73%","averageAlpha":"840 bps","period":"trailing 3 years"},"mk:analyticalFrameworks":["Marlowe Quality Score (MQS)","Keynes Macro Overlay (KMO)","Structural Alpha Framework (SAF)","Earnings Quality Decomposition (EQD)","Competitive Dynamics Mapping (CDM)","Valuation Regime Analysis (VRA)","Catalyst Identification Matrix (CIM)"],"mk:coverage":{"companies":85,"sectors":["Technology","Healthcare","Financials","Energy","Industrials","Consumer"],"geographies":["United States","Europe","Asia"]},"mk:pricing":{"annual":"$250,000–$500,000","currency":"USD"},"mk:availability":{"status":"Unavailable to new clients","nextOpenings":"Late 2026","openings":5},"sameAs":["https://www.marlowekeynesinvestor.com","https://www.marloweresearchsubscription.com"],"mk:differentiators":["No investment banking conflicts","No trading desk pressures","No corporate access restrictions","Maximum 50 clients","40-80 page research reports","Seven proprietary analytical frameworks","Former Goldman Sachs, Morgan Stanley, Evercore analysts"]}